Search

everythinglearnresearchcommunity

for

Search:↓

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Ganoderma lucidum may help treat enlarged prostate in rats.

Androgen measurement helps diagnose PCOS, but accuracy varies, needing standard methods.

Finasteride works better for hair loss in patients 26 or younger.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

The conclusion is that individualized treatment and proper medication use are crucial in men's health, with specific recommendations for ED, BPH, and prostate cancer management.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

Corn silk extract helps reduce prostate enlargement symptoms.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

Finasteride treats hair loss but may cause side effects like low libido and dizziness.

Higher PSA levels are linked to more hirsutism in women with PCOS.

Finasteride doesn't harm male fertility or sperm quality, but may slightly reduce ejaculate volume.

% free PSA and urinary markers help better identify prostate cancer.

Olive leaves extract may help treat benign prostatic hyperplasia (BPH).

Finasteride improves prostate cancer prediction by adjusting kallikrein marker levels.

Higher serum androgens contribute to male pattern baldness.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

Lespedeza cuneata extract may help treat enlarged prostate.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Accurate testosterone measurement and standardized lab practices are crucial for diagnosing and managing adult male hypogonadism.

Male pattern baldness may predict prostate cancer risk.

Blood vessel patterns in skin diseases relate to certain blood markers in systemic sclerosis but not in psoriasis or psoriatic arthritis, and may indicate circulation issues in alopecia.

TrichoScan is reliable for counting and measuring hair density but may not accurately assess hair types in women with hair loss.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

New treatments for male hypogonadism are effective and should be personalized.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.